Japan Science and Technology Agency (JST) Selects Scopus Custom Data for Citation Linkage Analysis Between Scientific Articles and Patents

AMSTERDAM, January 28 - Elsevier announced today that Scopus Custom Data, the underlying source
of Scopus.com, the world's largest abstract and citation database, was chosen
by Japan Science and Technology (JST) to conduct citation linkage analysis
between scientific articles and patents. JST, as the funding agency for
promoting innovation and providing research support to many organizations
from industry and academia, selected Scopus Custom Data because it provides
wider coverage and clear relations between authors and their affiliations.

According to a paper published by JST in the January edition of Journal
of Information Processing and Management , an analysis of research papers
cited in patents, shows the linkage between Japan's scientific articles and
technology is increasing every year and enabling Japan to maintain its
international competitiveness. It has also become clear that research papers
written by researchers funded by JST are having greater effects on technology
every year; and that JST is playing the political role of promoting the
creation of innovation as a funding agency. For details of the published
research paper, please refer to the website of Journal of Information
Processing and Management
www.jstage.jst.go.jp/article/johokanri/52/10/52_601/_article/-char/ja/
. The analysis was conducted by using the integrated search system for
research papers and patents developed by JST. JST plans to introduce this
system at the American Association for the Advancement of Science (AAAS) 2010
Annual Meeting, to be held from February 18 to 22, 2010 in San Diego, USA.

"Nowadays, there are needs to draw up policies for evidence-based
scientific technology and innovation, and to construct systems to measure and
evaluate them. JST has also began investigations toward achieving the
measurement of scientific technology and innovation; and as part of those
investigations, by analyzing the state of funding, research papers and
patents, JST is seeing influences that return on investment and science have
on technology. We selected Scopus Custom Data as the underlying database for
our analysis because it provides citation information, a large amount of
data, and clear relations between authors and their affiliations," commented
Mari Jibu of JST's Research Institute of Science and Technology for Society.

"Attention is being placed on citations in patents as a new index to
measure the influence of scientific articles. JST used Scopus data for its
analysis on the return on investment of science and technology policies. We
are honored to be able to cooperate with JST in this way, and will continue
to provide support from now on," added Niels Weertman, Director, Performance
& Planning and Collaboration Tools for Elsevier.

About Japan Science and Technology Agency (JST)

Japan Science and Technology Agency (JST) aims to establish Japan as a
nation built on the creativity of science and technology and innovation, as a
core organization for implementing Japan's science and technology policy in
line with the objectives of the Science and Technology Basic Plan. JST's
mission is to promote science and technology in Japan by conducting a broad
range of activities, including the following:

* Promotion of consistent research and development from basic research to
commercialization with particular emphasis on the creation of new
technological seeds

* Upgrading the infrastructure for the promotion of science and
technology, including dissemination of scientific and technological
information

For more information, please visit www.jst.go.jp/EN/index.html.

About Scopus.com and Scopus Custom Data

Covering the world's research literature, Scopus.com is the largest
abstract and citation database of peer-reviewed literature and quality web
sources with smart tools to track, analyze and visualize research. Its unique
database contains abstracts and references from 18,000 peer-reviewed journals
from more than 5,000 publishers worldwide, ensuring broad interdisciplinary
coverage. In addition, Scopus not only offers users citation information
about the articles covered, but also integrates web and patent searches
directly from its clean and simple interface. Direct links to full-text
articles, library resources and other applications like reference management
software, make Scopus quicker, easier and more comprehensive to use than any
other literature research tool. For more information about Scopus please
visit www.info.scopus.com

Scopus Custom Data provides research agencies, institutions and
government bodies with customized datasets in XML format for large-scale
research performance analysis. Scopus Custom Data extracts Scopus core
records in accordance to each customer's individual specifications, such as
date range, subject categories and geographic location. The XML data can then
be loaded by customers into their proprietary in-house systems, making it
possible for them to run their specific search queries and execute their own
analytical techniques; providing the analyst with the freedom to formulate
their own reports. It empowers them to make well-informed, unbiased resource
allocation and policy making decisions.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com),
Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and
Nursing Consult (www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com) and MEDai's Pinpoint Review (www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact:
    Nami Kanda
    Elsevier
    +81-35561-5069
    n.kanda@elsevier.com

Media Contact: Nami Kanda, Elsevier, +81-35561-5069, n.kanda at elsevier.com